-
Smartphone App, Device Shown to Measure Blood Pressure
A smartphone-based system and app were shown in a pilot study with human subjects to measure a person’s blood pressure with about the same accuracy as some cuff devices normally used to gauge blood pressure.
-
What Exactly Is Pharmaceutical Market Access?
Market access is a process which is out in place to ensure that any patient who is appropriate for receiving a certain medicine is able to receive it at a decent price.
-
A.I. Shown to Boost Cancer Clinical Trial Enrollment
Early results from a system using a supercomputer and artificial intelligence to match breast cancer patients to clinical trials shows faster screening and higher enrollment rates in these studies compared to manual methods.
-
Evotec Acquiring Sanofi Infectious Disease Portfolio
Drug discovery company Evotec AG is licensing 10 infectious disease R&D programs and their 100 employees from drug maker Sanofi, and opening new labs for this work in Lyon, France.
-
Peptide Hydrogel Boosts Cancer Immunotherapies
A team at Rice University in Houston developed an injectable gel material that in lab mice slows the release of cancer immunotherapy drugs, enhancing the treatments’ effectiveness and reducing the need for repeated doses.
-
The Powerful Art Of Planning To Suit You
When a new project comes up, you must plan it to suit you. Here’s how you can relay that to your entire firm, and allow this process to proceed along your lines.
-
Company Formed to Develop Cancer Cell Therapies
The MD Anderson Cancer Center in Houston is starting Optera Therapeutics Corp., a new company to commercialize its research on treating cancer with a patients’ own immune system cells.
-
FDA Clears Consumer Genetic Breast Cancer Risk Tests
The Food and Drug Administration authorized the first direct-to-consumer tests of genetic risk for cancer, in this case 3 variations of genes associated with higher risk of breast and ovarian cancer.
-
Institute, Company Studying Neuro Disease Proteins
The Montreal Neurological Institute and Thermo Fisher Scientific are beginning a study of 30 proteins implicated in neurodegenerative diseases to validate related antibodies and reagents for advancing treatments.
-
3-D Biomaterial Boosts Personal Cancer Immunotherapy
A Harvard University bioengineering lab developed an injectable material designed to load up with proteins from a patient’s own tumors to induce immune reactions that fight that person’s cancer.